Allocate All Savings from Off-Year Drug Re-Pricing to Medical Fees: Hodanren

The Japanese Medical and Dental Practitioners for the Improvement of Medical Care (Hodanren) on August 30 issued a statement on the next “off-year” drug price revision scheduled for April 2023, calling for all savings obtained from re-pricing to be used...read more